Magnetic resonance spectroscopy and diffusion Weighted imaging characterization of Supratentorial brain tumors: a one year Hospital based cross sectional study

Abstract

Background and objectives: Tumors within the brain represent a serious health concern. Subtypes of brain cancers include infra- and supra-tentorial brain tumors. It is frequently challenging to distinguish low-grade from high-grade gliomas and neoplastic from non-neoplastic brain masses with conventional MRI, and many patients necessitate biopsy or further imaging. Modern methods of magnetic resonance imaging, such magnetic resonance spectroscopy, can increase the diagnostic precision of magnetic resonance imaging when identifying these types of cancers. Magnetic resonance spectroscopy can be used to study brain metabolites and tumors, which also enables follow-up and therapy response assessment. These metabolites can provide insight into the type of lesions and brain malignancies. Identifying molecules and learning about their biophysical properties are two analytical uses for magnetic resonance spectroscopy. As a result, this method is a multi-parametric molecular imaging methodology that can successfully complement a magnetic resonance imaging research and identify biochemical patterns of many characteristics and facets of brain tumors. Diffusion-weighted imaging (DWI) uses the minute movement of water molecules to reveal more information about the brain. Diffusion-weighted imaging (DWI) has been used to distinguish between brain tumors with high and low cell numbers, as well as to identify the type of brain tumor based on the density of cells. The study was undertaken to characterize supra-tentorial tumors using magnetic resonance spectroscopy & diffusion weighted imaging in addition to other magnetic resonance imaging (conventional)